However, VCaP cells, which display the TMPRSS2-ERG fusion, display increased risk of PCa progression after treatment with PDE5 inhibitors (119), demonstrating that PCa cells display different properties and behavior in response to PDE5 inhibition. The gene discussed is TMPRSS2; the disease is posterior cortical atrophy.